UBT-37034

N/A

Report date: 2025/09/30 11:29:49
NME

Base Information

Drug NameUBT-37034
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNeuropeptide Y receptor type 2 agonists
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLianbang Biotechnology (Zhuhai Hengqin) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLianbang Biotechnology (Zhuhai Hengqin) Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A